Micrologic's New nanoRV Release Supports Innovative Newest FinFET Technology

Micrologic Design Automation, Inc. ("MDA"), a leader in software development for electronic manufacturers, today announced the new release of its nanoRV tool for enhanced reliability and performance of custom and semi-custom integrated circuit (IC) layouts.

MDA specializes in development of interactive software tools and online verification software to enhance the cutting-edge next-generation development of electronic devices.

MDA has signed recently a certain evaluation agreement to promote Micrologic's technology for Integrated Circuit (IC) design with one of the industry leaders in semiconductor manufacturing, and Forex International Trading Corp (OTCBB: FXIT) is contemplating investing in MDA to support Micrologic's market penetration. Micrologic is planning of take part in a promising new area of technology growth. Many of the biggest transistor and semiconductor chip manufacturers that design and manufacture smaller-scale devices utilize a new multiple gate field-effect transistor called FinFET. Micrologic's CTO Dr. Danny Rittman explained: "Micrologic's proprietary nanoRV™ new release fully supports the innovative newest FinFET Technology."

Continued Dr. Rittman: "The attractiveness of FinFET technology lies in the realization of self-aligned double-gate devices with a conventional CMOS process. This allows extending the gate scaling beyond the planar transistor limits, maintaining a steep sub-threshold slope, better performance with bias voltage scaling and good matching due to low doping concentration in the channel. There are, however, several challenges and roadblocks that FinFET technology has to face to be competitive with other technology options: one of the major ones is reliability."

Furthermore, according to Dr. Rittman, "IC designers are under tremendous pressure to accelerate the signoff of modern FinFET-based manufacturing processes. Complex geometries of 16nm, 14nm FinFET based are presenting a whole world of difference when it comes to design rules. Microchips designed with these processes are taking much longer, causing major challenges for IC Design houses. The desire to reduce cost and speed time to market is only matched by IC designers' demand for the highest level of confidence in the performance and reliability of the design and the design signoff verification tools. Accelerating signoff verification is mission-critical for us and for our collaborating IC design customers who demanded features and tested nanoRV interactive signoff validation with real customer designs. We are proud to introduce full support for the FinFET Technologies which will enhance the capabilities of IC design houses as an option to replace existing technology, keeping milestones and schedules on-time."

About Micrologic
Micrologic Design Automation, Inc. is a high-tech software company that is developing interactive and online software solutions for larger electronic manufacturers development with its proprietary technology nanoToolBox™, an interactive electronic design automation tool suite. Micrologic's software tools interactively perform reliability enhancement with automatic correction to the user. Micrologic solutions reduce cost, speed time to market and improve reliability and performance of complex small nanometer designs to develop the next generation of electronic devices. Micrologic received certification from the leading electronic organization in Japan who is integrating all largest Japan world known electronic manufacturers called STARC. Micrologic is headquartered in California and operates its R&D Center in Haifa Israel. For more information please visit www.micrologic-da.com

Press release avilable from http://www.prnewswire.com/

Source:

Micrologic Design Automation, Inc.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.